For: | Chen L, Xu J, Deng M, Liang Y, Ma J, Zhang L, Wang Y, Zhang J. Telmisartan mitigates lipopolysaccharide (LPS)-induced production of mucin 5AC (MUC5AC) through increasing suppressor of cytokine signaling 1 (SOCS1). Bioengineered 2021;12:3912-23. [PMID: 34281463 DOI: 10.1080/21655979.2021.1943605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Gao Y, Li S, Dong R, Li X. Long noncoding RNA MIR3142HG accelerates lipopolysaccharide-induced acute lung injury via miR-95-5p/JAK2 axis. Human Cell. [DOI: 10.1007/s13577-022-00687-4] [Reference Citation Analysis] |
2 | Liang J, Zhuang R, Sun X, Zhang F, Zou B. Apremilast mitigates interleukin (IL)-13-induced inflammatory response and mucin production in human nasal epithelial cells (hNECs). Bioengineered 2021;12:8583-93. [PMID: 34607526 DOI: 10.1080/21655979.2021.1987818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis] |
3 | Guo J, Xu S. Astragaloside IV suppresses histamine-induced inflammatory factors and mucin 5 subtype AC overproduction in nasal epithelial cells via regulation of inflammation-related genes. Bioengineered 2021;12:6045-56. [PMID: 34482800 DOI: 10.1080/21655979.2021.1965813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis] |